This company listing is no longer active
Bioservo Technologies Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Wichtige Informationen
n/a
Wachstumsrate der Gewinne
n/a
EPS-Wachstumsrate
| Medical Equipment Gewinnwachstum | 30.4% |
| Wachstumsrate der Einnahmen | 56.4% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | n/a |
Jüngste Aktualisierungen zum künftigen Wachstum
Keine Aktualisierungen
Recent updates
Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2024 | 61 | N/A | -24 | -19 | 1 |
| 12/31/2023 | 36 | N/A | -24 | -21 | 1 |
| 12/31/2022 | 17 | N/A | -42 | -39 | 1 |
| 6/30/2022 | 17 | -39 | -40 | -38 | N/A |
| 3/31/2022 | 13 | -38 | -41 | -39 | N/A |
| 12/31/2021 | 11 | -35 | -36 | -34 | N/A |
| 9/30/2021 | 7 | -34 | -30 | -29 | N/A |
| 6/30/2021 | 5 | -34 | -24 | -23 | N/A |
| 3/31/2021 | 10 | -28 | -19 | -18 | N/A |
| 12/31/2020 | 14 | -26 | -18 | -17 | N/A |
| 9/30/2020 | 22 | -25 | -26 | -25 | N/A |
| 6/30/2020 | 23 | -24 | -24 | -23 | N/A |
| 3/31/2020 | 25 | -25 | -25 | -24 | N/A |
| 12/31/2019 | 24 | -23 | -27 | -26 | N/A |
| 9/30/2019 | 23 | -27 | -22 | -21 | N/A |
| 6/30/2019 | 21 | -28 | -32 | -29 | N/A |
| 3/31/2019 | 17 | -27 | -22 | -19 | N/A |
| 12/31/2018 | 16 | -28 | -22 | -17 | N/A |
| 9/30/2018 | 15 | -23 | -22 | -17 | N/A |
| 6/30/2018 | 14 | -21 | -18 | -13 | N/A |
| 3/31/2018 | 12 | -22 | -29 | -23 | N/A |
| 12/31/2017 | 12 | -19 | -22 | -16 | N/A |
| 9/30/2017 | 11 | -17 | -21 | -15 | N/A |
| 6/30/2017 | 11 | -16 | -19 | -14 | N/A |
| 3/31/2017 | 12 | -12 | -14 | -9 | N/A |
| 12/31/2016 | 11 | -13 | -18 | -13 | N/A |
| 12/31/2015 | 11 | -7 | N/A | N/A | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: Insufficient data to determine if BIOS BTU's forecast earnings growth is above the savings rate (0.4%).
Ertrag vs. Markt: Insufficient data to determine if BIOS BTU's earnings are forecast to grow faster than the Swedish market
Hohe Wachstumserträge: Insufficient data to determine if BIOS BTU's earnings are expected to grow significantly over the next 3 years.
Einnahmen vs. Markt: BIOS BTU's revenue (56.4% per year) is forecast to grow faster than the Swedish market (9.3% per year).
Hohe Wachstumseinnahmen: BIOS BTU's revenue (56.4% per year) is forecast to grow faster than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Insufficient data to determine if BIOS BTU's Return on Equity is forecast to be high in 3 years time